Summary
Fifteen bile acids in serum of 5 normal subjects and 21 patients with chronic liver diseases were fractionated by high performance liquid chromatography. Fasting total bile acids (TBA), glycocholic acid, taurocholic acid, glycochenodeoxycholic acid (GCDCA), and taurochenodeoxycholic acid (TCDCA) were significantly increased in patients with liver cirrhosis as compared with normal subjects. The cholic acid (CA) level and the ratio of the sum of free and conjugated CA to the sum of free and conjugated chenodeoxycholic acid (CDCA) were significantly elevated in patients with compensated as compared with decompensated liver cirrhosis, and were useful for differentiation of the two conditions.
Serum bile acid levels were determined after oral administration of 500 mg of CDCA in the 5 normal subjects and 11 patients with liver disease. The TBA level reached a peak 90 min after CDCA administration in patients with chronic hepatitis and after 120 min in those with liver cirrhosis. The increase in the TBA level was significantly greater in patients with liver disease than in normal subjects. CDCA, GCDCA, and TCDCA showed changes similar to those in TBA. In patients with decompensated liver cirrhosis, the reduction in the TBA and CDCA levels after the peaks was slow, and GCDCA and TCDCA levels continued to increase until 180 min after the administration of CDCA. The TBA and CDCA levels 180 min after CDCA administration were significantly different among normal subjects, patients with chronic hepatitis, those with compensated liver cirrhosis, and those with decompensated liver cirrhosis, suggesting the usefulness of CDCA administration in differentiation of these conditions.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berry W, Reichen J: Bile acid metabolism: Its relation to clinical disease. Semin Liver Dis 1983;3:330–340
Hasegawa S, Uenoyama R, Takeda F, et al: A fully automatic method for analysis of individual bile acids in the serum using high-performance liquid chromatography for clinical use. J Liquid Chromat 1984;7:2267–2287
Barnes S, Gallo GA, Trash DB, et al: Diagnostic value of serum bile acid estimations in liver disease. J Clin Pathol 1975;28: 506–509
Fausa O, Gjone E: Serum bile acid concentrations in patients with liver disease. Scand J Gastroenterol1976;11:537–543
Monroe PS, Baker AL, Schneider JF, et al: The aminopyrine breath test and serum bile acids reflect histologic severity in chronic hepatitis. Hepatology 1982;2:317–322
VanBlankenstein M, Frekel M, Van Den Berg JWO, et al: Endogenous bile acid tolerance test for liver function. Dig Dis Sci 1983;28:137–144
Pennington CR, Ross PE, Bouchier IAD: Serum bile acid in the diagnosis of hepatobiliary disease. Gut 1977;18:903–908
Morita T, Matsuyama Y, Fujimoto T, et al: Clinical significance of serum bile acid measurement in liver disease. Gastroenterol Jpn 1987;13:491–502
Matern S, Gerok W: Diagnostic value of serum bile acids. Acta Hepato-Gastroenterol 1979;26:185–189
Bremmelgaad A, Alme B: Analysis of plasma bile acid profiles in patients with liver diseases associated with cholestasis. Scand J Gastroenterol 1980;15:593–600
Kimura H, Takahashi W, Suzuki N, et al; Separatory determinatin of free and conjugated bile acids in human serum and its clinical significance. Jpn J Gastroenterol1981;78:1079–1087 (in Jpn)
Okuyama S: Analysis of free, glycine-and taurine-conjugated individual bile acids using high performance liquid chromatography and immobilized 3α-hydroxysteroid dehydrogenase in column form. Jpn J Clin Pathol 1981;29:446–458 (in Jpn)
Uenoyama R: Evaluation of the serum bile acid measurement for the diagnosis of liver diseases, with special reference to individual serum bile acids in hepatobiliary diseases. Jpn J Clin Pathol 1981;29:478–484 (in Jpn)
Okuda H, Obata H, Nakanishi T, et al: Quantification of individual serum bile acids in patients with liver diseases using high-performance liquid chromatography. Hepato-Gastroenterology 1984;31:168–171
McCormick WCIII, Bell CCJr, Swell L, et al: Cholic acid synthesis as an index of the severity of liver desease in man. Gut 1973;14:895–902
Matsumoto H, Masamune O, Nunode Y, et al: Diagnostic value of oral bile acid tolerance test. Jpn J Gastroenterol 1981;78:1380–1387 (in Jpn)
Matsuzaki Y, Osuga T, Imawari M, et al: Clinical significance of the determination of serum individual bile acid and oral bile acid loading test in gastrointestinal diseases. Jpn J Gastroenterol1985;82:1369–1379 (in Jpn)
Hirayama C, Yamanishi Y, Wakushima T: Analysis of bile acid and bile acid tolerance test. Jpn J Clin Med 1979, 37:2393–2395 (in Jpn)
Inaguma H, Katagiri K, Hayaka T, et al: Change of serum bile acid levels after administration of UDCA and test meals. Jpn J Gastroenterol 1982;79:282 (in Jpn)
Tashiro A: Oral ursodeoxycholic acid tolerance test for patients with hepatobiliary disease. Acta Hepat Jap 1979;20:369–376 (in Jpn)
Islam S, Poupnon RE, Barbare JC, et al: Fasting serum bile acid levels in cirrhosis. A semi-quantitative index of hepatic function. J Hepatol 1985;1:609–617
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Adachi, Y., Nanno, T., Itoh, T. et al. Determination of individual serum bile acids in chronic liver diseases: Fasting levels and results of oral chenodeoxycholic acid tolerance test. Gastroenterol Jpn 23, 401–407 (1988). https://doi.org/10.1007/BF02779208
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02779208